glp-1 and synthroid Thyroid Medication: Safe Combined Use Suppressed thyroid stimulating hormone levels

In addition, the GLP-1 enhancer sitagliptin exerts a protective role against diabetic cardiomyopathy via the GLP-1/PPAR pathway [36]

Intravenous curcumin was the preferred treatment based off of high sensitivity on chemosensitivity testing done at a lab in Greece

PMID 9771526

Based on the CVOTs, the treatment algorithm of T2D has changed to include GLP-1RAs independent of glycaemia in patients with established CVD or high-risk (96)

Sherwin et al (2023) : Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide Twenty patients were given semaglutide or a control, with the following results after an 8-hour fasting period: Supine position: 70% of semaglutide participants and 10% of control participants had solids present on gastric ultrasound

Depending on their medical history, diabetic patients may also have other factors impacting their gastric emptying (Table 7)